Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01174511Phase 2Unknown
Phase 2, randomised, double-blind trial of A-1 Cool Cream in atopic dermatitis (AD) (2 arms), sponsored by Hadassah Medical Organization. Primary endpoint: Three Item Severity Score at 5 days. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01174511.